SCHEMBL8360559

SCHEMBL8360559

CCn1c(C)c(NC(C)=O)c2cc(Cl)ccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.50
ALDH1A1 P00352 4/20 0.50
MAPT P10636 4/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
HPGD P15428 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP2C19 P33261 2/20 0.50
HTT P42858 1/20 0.50
RECQL P46063 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.48
PTGER4 P35408 1/20 0.48
MAPK1 P28482 3/20 0.45
PTGDR2 Q9Y5Y4 2/20 0.45
RORC P51449 1/20 0.45
HTR6 P50406 1/20 0.44
HSD17B10 Q99714 2/20 0.44
LMNA P02545 1/20 0.44
CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8649405 0.75 ALDH1A1 (0.60) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL8645800 0.75 CNR2 (0.55) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL27475357 0.75 ALDH1A1 (0.51) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL8360558 0.74 ALDH1A1 (0.50) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL8351871 0.73 HSD17B10 (0.46) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL1921261 0.73 PTGER4 (0.72) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL7726215 0.70 NPSR1 (0.86) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL22003802 0.70 HTR6 (0.56) KDM4EALDH1A1MAPTHPGDCYP1A2
SCHEMBL5795918 0.69 ALDH1A1 (0.62) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL17396548 0.68 ALDH1A1 (0.49) KDM4EALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5877202-A Indole derivatives useful to treat estrogen-related neoplasms and disorders AVENTISUB II INC. 1999-03-02 US disclosed